Lung Cancer, Nonsmall Cell, Stage I Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: NSCLC, Stage I / Stage I NSCLC / Stage I Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer Stage I / Lung cancer non-small cell stage I

IndicationStatusPhase
DBCOND0081601 (Lung Cancer, Nonsmall Cell, Stage I)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05686434Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)Treatment